Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Pemberton

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Expert Review of Vaccines|January 24, 2020
An oral bait vaccination approach for the Tasmanian devil facial tumor diseasesAndrew S Flies, Emily J Flies, Samantha Fox, et al.
Royal Society Open Science|November 27, 2018
Tasman-PCR: a genetic diagnostic assay for Tasmanian devil facial tumour diseasesYoung Mi Kwon, Maximilian R Stammnitz, Jinhong Wang, et al.
The Journal of Applied Ecology|August 10, 2018
Density trends and demographic signals uncover the long-term impact of transmissible cancer in Tasmanian devilsBillie T Lazenby, Mathias W Tobler, William E Brown, et al.
Frontiers in Immunology|March 9, 2018
Immunization Strategies Producing a Humoral IgG Immune Response against Devil Facial Tumor Disease in the Majority of Tasmanian Devils Destined for Wild ReleaseRuth Pye, Amanda Patchett, Elspeth McLennan, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 30, 2015
A second transmissible cancer in Tasmanian devilsRuth J Pye, David Pemberton, Cesar Tovar, et al.
The Medical Journal of Australia|March 15, 2023
Eliminating hepatitis C in Australia: a novel model of hepatitis C testing and treatment for people who inject drugs at a medically supervised injecting facilityMichael B MacIsaac, Bradley Whitton, Adrian Hubble, et al.
Evolutionary Applications|September 25, 2019
Tracing the rise of malignant cell lines: Distribution, epidemiology and evolutionary interactions of two transmissible cancers in Tasmanian devilsSamantha James, Geordie Jennings, Young Mi Kwon, et al.
The International Journal on Drug Policy|January 28, 2024
Point-of-care HCV RNA testing improves hepatitis C testing rates and allows rapid treatment initiation among people who inject drugs attending a medically supervised injecting facilityMichael B MacIsaac, Bradley Whitton, Jenine Anderson, et al.
Plos Biology|November 24, 2020
Evolution and lineage dynamics of a transmissible cancer in Tasmanian devilsYoung Mi Kwon, Kevin Gori, Naomi Park, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Expert Review of Vaccines|January 24, 2020
An oral bait vaccination approach for the Tasmanian devil facial tumor diseasesAndrew S Flies, Emily J Flies, Samantha Fox, et al.
Royal Society Open Science|November 27, 2018
Tasman-PCR: a genetic diagnostic assay for Tasmanian devil facial tumour diseasesYoung Mi Kwon, Maximilian R Stammnitz, Jinhong Wang, et al.
The Journal of Applied Ecology|August 10, 2018
Density trends and demographic signals uncover the long-term impact of transmissible cancer in Tasmanian devilsBillie T Lazenby, Mathias W Tobler, William E Brown, et al.
Frontiers in Immunology|March 9, 2018
Immunization Strategies Producing a Humoral IgG Immune Response against Devil Facial Tumor Disease in the Majority of Tasmanian Devils Destined for Wild ReleaseRuth Pye, Amanda Patchett, Elspeth McLennan, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 30, 2015
A second transmissible cancer in Tasmanian devilsRuth J Pye, David Pemberton, Cesar Tovar, et al.
The Medical Journal of Australia|March 15, 2023
Eliminating hepatitis C in Australia: a novel model of hepatitis C testing and treatment for people who inject drugs at a medically supervised injecting facilityMichael B MacIsaac, Bradley Whitton, Adrian Hubble, et al.
Evolutionary Applications|September 25, 2019
Tracing the rise of malignant cell lines: Distribution, epidemiology and evolutionary interactions of two transmissible cancers in Tasmanian devilsSamantha James, Geordie Jennings, Young Mi Kwon, et al.
The International Journal on Drug Policy|January 28, 2024
Point-of-care HCV RNA testing improves hepatitis C testing rates and allows rapid treatment initiation among people who inject drugs attending a medically supervised injecting facilityMichael B MacIsaac, Bradley Whitton, Jenine Anderson, et al.
Plos Biology|November 24, 2020
Evolution and lineage dynamics of a transmissible cancer in Tasmanian devilsYoung Mi Kwon, Kevin Gori, Naomi Park, et al.
Pageof 2